SEC Filing Form 4 Summary

This filing details a Form 4 filing for Apogee Therapeutics, Inc. (APGE), reporting transactions by Mark C. McKenna, a director. On September 3, 2026, McKenna disposed of 20,000 shares of Common Stock and several stock options. These transactions were executed under the terms of a Merger Agreement with Andor LLC, Andor Merger Co., and AbbVie Inc. The stock options were vested at the time of the merger or became fully vested in connection with it. Each option was disposed of in exchange for a cash payment calculated as the difference between the merger consideration of $135.11 per share and the option's exercise price. McKenna no longer holds any direct or indirect ownership of these securities following the transactions.